Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01867008 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the Cochlear Nucleus CI422 Cochlear Implant in Adults
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT01867008: Completed NA study, sponsored by Cochlear.
NCT01867008 is a NA study that has completed, run by Cochlear. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01867008, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
Clinical study to evaluate the safety and efficacy of the Cochlear™ Nucleus® CI422 cochlear implant for new cochlear implant adult recipients with broader requirements to be considered an eligible candidate.
Primary Outcome
Performance at 6 months postactivation compared to pre-operative word recognition score (percent correct: 0-100%, where a 0% is the lowest score and a 100% is the highest score)
Interventions
- DEVICE Nucleus CI422 Cochlear Implant with N6 Sound Processor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT01867008 record still lists
NCT01867008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Nucleus CI422 Cochlear Implant with N6 Sound Processor is the first listed.
NCT01867008 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01867008 about?
NCT01867008 is a clinical study titled "Safety and Efficacy of the Cochlear Nucleus CI422 Cochlear Implant in Adults". Clinical study to evaluate the safety and efficacy of the Cochlear™ Nucleus® CI422 cochlear implant for new cochlear implant adult recipients with broader requirements to be considered an eligible candidate.
What is the current status of trial NCT01867008?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2013-08. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01867008?
The interventions under investigation include: Nucleus CI422 Cochlear Implant with N6 Sound Processor (DEVICE).
Who is sponsoring clinical trial NCT01867008?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01867008's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia